Prestige EHV 1/4 from Merck Animal Health is an inactivated equine vaccine labeled for use in horses to aid in the prevention of equine herpesvirus type 1 (EHV-1) and equine herpesvirus type 4 (EHV-4). This vaccine is formulated to support protection against respiratory disease associated with these common equine pathogens.
Prestige EHV 1/4 is indicated for use as part of a routine equine vaccination program, particularly for horses at risk of exposure through training, competition, transport, or group housing. The vaccine is administered by intramuscular injection according to label directions and veterinary guidance.
